Report date: Nov 6,2024
Conflict count: 361874
Publisher: Geneesmiddelenbulletin Foundation
Title count: 1
Conflict count: 3


==========================================================

Created: 2022-03-31 09:12:35
ConfID: 6460676
CauseID: 1525305227
OtherID: 1514963137
JT: Ge-Bu
MD: Stolk,117 119,11,1,2021,Living systematic reviews
DOI: 10.35351/gebu.2021.11.21(Journal) (6460676-N)
DOI: 10.35351/gebu.nl.2021.11.21(Journal)
==========================================================

Created: 2022-08-29 07:28:00
ConfID: 6578543
CauseID: 1539942866
JT: Ge-Bu
MD: Stolk,37 39,5,1,2022,Antiviral drugs for COVID-19
DOI: 10.35351/gebu.2022.5.19(Journal) (6578543-N)
DOI: 10.35351/gebu.2022.5.9(Journal)
==========================================================

Created: 2022-03-30 08:52:02
ConfID: 6459660
CauseID: 1525180708
OtherID: 1497282136
JT: Ge-Bu
MD: Cox,35 40,4,1,2021,Erlotinib
DOI: 10.35351/gebu.2021.4.8(Journal) (6459660-N)
DOI: 10.35351/gebu.nl.2021.4.8(Journal)